SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 623.11 |
| Enterprise Value ($M) | 578.88 |
| Book Value ($M) | 273.99 |
| Book Value / Share | 3.88 |
| Price / Book | 2.27 |
| NCAV ($M) | 251.35 |
| NCAV / Share | 3.56 |
| Price / NCAV | 2.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.15 |
| Current Ratio | 13.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 279.43 |
| Assets | 302.07 |
| Liabilities | 28.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nextech Crossover I GP S.a r.l. | 7.50 | 23.33 | |
| 13G/A | EcoR1 Capital, LLC | 4.90 | -45.53 | |
| 13G/A | Column Group Ii, Lp | 5.20 | -0.75 | |
| 13G/A | Alkeon Capital Management Llc | 5.50 | 8.32 | |
| 13G/A | Fmr Llc | 6.21 | -14.05 | |
| 13G | BlackRock, Inc. | 7.20 | 0.00 | |
| 13G/A | Prosight Management, LP | 2.90 | -30.80 | |
| 13G/A | Millennium Management Llc | 0.00 | -100.00 | |
| 13G | Venrock Healthcare Capital Partners III, L.P. | 6.60 | ||
| 13G | Viking Global Investors Lp | 5.90 | ||
| 13G | Frazier Life Sciences Public Fund, L.P. | 6.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 90,323 | 553,273 | 16.33 | |
| 96,780 | 670,363 | 14.44 | |
| 44,114 | 213,566 | 20.66 | |
| 56,216 | 205,954 | 27.30 | |
| 33,151 | 200,498 | 16.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OMGA – Omega Therapeutics, Inc. | OPK – OPKO Health, Inc. |
| OPTN – OptiNose, Inc. | OVID – Ovid Therapeutics Inc. |
| PASG – Passage Bio, Inc. |
Financial data and stock pages provided by
Fintel.io